Immediate Impact
2 from Science/Nature 72 standout
Citing Papers
Pancreatic cancer
2025 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Jiro Ohuchida being referenced
Randomized Controlled Trial for Efficacy of Nafamostat Mesilate in Preventing Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis
2014
Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Jiro Ohuchida | 938 | 743 | 505 | 61 | 1.3k | |
| Ichiro Hirai | 901 | 913 | 455 | 63 | 1.4k | |
| Jean‐François Gigot | 934 | 851 | 490 | 53 | 1.5k | |
| Neil R. Thomford | 728 | 549 | 567 | 62 | 1.4k | |
| Masatoshi Isogai | 741 | 458 | 439 | 107 | 1.1k | |
| Yasutsugu Bandai | 1117 | 410 | 800 | 63 | 1.6k | |
| Genoveffa Balducci | 814 | 511 | 355 | 91 | 1.3k | |
| Sung Hoon Choi | 975 | 837 | 628 | 94 | 1.3k | |
| Byong Ro Kim | 666 | 618 | 346 | 46 | 1.0k | |
| Kengo Fukuzawa | 526 | 426 | 266 | 65 | 1.0k | |
| Dongwook Oh | 1058 | 1054 | 758 | 95 | 1.4k |
All Works
Loading papers...